Table 1.
WHO group1 | n (%) |
---|---|
I (PAH) | 23 (76%) |
‐idiopathic/heritable | 14 |
‐congenital heart disease | 4 |
‐connective tissue disease | 3 |
‐portopulmonary hypertension | 1 |
‐hemolytic disorder | 1 |
II (Heart disease) | 2 (7%) |
‐left ventricular diastolic dysfunction | 2 |
III (Lung disease) | 2 (7%) |
‐COPD | 2 |
IV (CTEPH) | 1 (3%) |
V (miscellaneous) | 2 (7%) |
‐sarcoidosis | 2 |
CTEPH = chronic thromboembolic pulmonary hypertension; PAH = pulmonary arterial hypertension.